M
Michael Gurevich
Researcher at Tel Aviv University
Publications - 14
Citations - 302
Michael Gurevich is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Multiple sclerosis & Gene expression. The author has an hindex of 6, co-authored 14 publications receiving 233 citations. Previous affiliations of Michael Gurevich include Rabin Medical Center & Sheba Medical Center.
Papers
More filters
Journal ArticleDOI
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
Anat Achiron,Irena Kishner,Ida Sarova-Pinhas,Havi Raz,Meir Faibel,Yael Stern,Mor Lavie,Michael Gurevich,Mark Dolev,David Magalashvili,Yoram Barak +10 more
TL;DR: Intravenous immunoglobulin treatment for the first year from onset of the first neurological event suggestive of demyelinative disease significantly lowers the incidence of a second attack and reduces disease activity as measured by brain magnetic resonance imaging.
Journal ArticleDOI
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: A randomized, double-blind, placebo-controlled trial
Anat Achiron,Irena Kishner,Ida Sarova-Pinhas,Havi Raz,Meir Faibel,Yael Stern,Mor Lavie,Michael Gurevich,Mark Dolev,David Magalashvili,Yoram Barak +10 more
TL;DR: Intravenous immunoglobulin treatment for the first year from onset of the first neurological event suggestive of demyelinative disease significantly lowers the incidence of a second attack and reduces disease activity as measured by brain magnetic resonance imaging.
Journal ArticleDOI
Monocyte chemoattractant protein-1 in the aqueous humour of patients with age-related macular degeneration.
Michal Kramer,Murat Hasanreisoglu,Anna Feldman,Anna Feldman,Ruth Axer-Siegel,Paulina Sonis,Idit Maharshak,Yehudit Monselise,Michael Gurevich,Michael Gurevich,Dov Weinberger +10 more
TL;DR: The objective was to investigate the role of inflammation in age‐related macular degeneration by measuring the levels of cytokines in the aqueous humour to find out if these levels are driven by inflammation or by other mechanisms.
Journal ArticleDOI
SARS-COV-2 antibody dynamics and B-cell memory response over-time in COVID-19 convalescent subjects.
TL;DR: In this article, the authors evaluated long-term IgG antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and B-cell memory response in COVID-19 convalescent subjects.
Journal ArticleDOI
Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.
TL;DR: Gen expression microarrays in peripheral blood mononuclear cells indicate that cytokine-associated genes are involved in various pathogenic pathways in MS and also related to immunomodulatory treatment effects.